Jaramillo-Valverde, L.; Levano, K.S.; Tarazona, D.D.; Vasquez-Dominguez, A.; Toledo-Nauto, A.; Capristano, S.; Sanchez, C.; Tarazona-Santos, E.; Ugarte-Gil, C.; Guio, H.
GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients. Int. J. Mol. Sci. 2022, 23, 11028.
https://doi.org/10.3390/ijms231911028
AMA Style
Jaramillo-Valverde L, Levano KS, Tarazona DD, Vasquez-Dominguez A, Toledo-Nauto A, Capristano S, Sanchez C, Tarazona-Santos E, Ugarte-Gil C, Guio H.
GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients. International Journal of Molecular Sciences. 2022; 23(19):11028.
https://doi.org/10.3390/ijms231911028
Chicago/Turabian Style
Jaramillo-Valverde, Luis, Kelly S. Levano, David D. Tarazona, Andres Vasquez-Dominguez, Anel Toledo-Nauto, Silvia Capristano, Cesar Sanchez, Eduardo Tarazona-Santos, Cesar Ugarte-Gil, and Heinner Guio.
2022. "GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients" International Journal of Molecular Sciences 23, no. 19: 11028.
https://doi.org/10.3390/ijms231911028
APA Style
Jaramillo-Valverde, L., Levano, K. S., Tarazona, D. D., Vasquez-Dominguez, A., Toledo-Nauto, A., Capristano, S., Sanchez, C., Tarazona-Santos, E., Ugarte-Gil, C., & Guio, H.
(2022). GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients. International Journal of Molecular Sciences, 23(19), 11028.
https://doi.org/10.3390/ijms231911028
